Examination of Aggression and Self-injury in Children with Autism Spectrum Disorders and Serious Behavioral Problems

Child and Adolescent Psychiatric Clinics of North America

Volumn 23, Issue 1, 2014, Pages 57-72

  Carroll, Devon ^a   Hallett, Victoria ^b   McDougle, Christopher J ^c   Aman, Michael G ^d   McCracken, James T ^e   Tierney, Elaine ^f   Arnold, L Eugene ^d   Sukhodolsky, Denis G ^g   Lecavalier, Luc ^d   Handen, Benjamin L ^h   Swiezy, Naomi ⁱ   Johnson, Cynthia ^h   Bearss, Karen ^j   Vitiello, Benedetto ^k   Scahill, Lawrence ^j  

^a Family and Children's Aid   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c HARVARD UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Yale University ^*

^g YALE UNIVERSITY   (United States)

^h UNIVERSITY OF PITTSBURGH   (United States)

ⁱ INDIANA UNIVERSITY   (United States)

^j EMORY UNIVERSITY   (United States)

^k NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

more..

Author keywords

Aggression; Autism; Disruptive behavior; Self injury

Indexed keywords

PLACEBO; RISPERIDONE;

ADOLESCENT; AGGRESSION; AGGRESSIVENESS; AUTISM; AUTOMUTILATION; BEHAVIOR; CHILD; CLINICAL FEATURE; COLD AGGRESSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HOT AGGRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONAGGRESSION; PARENTAL STRESS; PATIENT ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW;

AGGRESSION; AUTISM; DISRUPTIVE BEHAVIOR; SELF-INJURY;

ADOLESCENT; AGGRESSION; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTELLIGENCE TESTS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISPERIDONE; SELF-INJURIOUS BEHAVIOR; SEVERITY OF ILLNESS INDEX;

EID: 84887558437     PISSN: 10564993     EISSN: 15580490     Source Type: Journal    
DOI: 10.1016/j.chc.2013.08.002     Document Type: Review

References (54)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, text revision, American Psychiatric Association, Washington, DC. 4th edition.
2. Autism and Developmental Disabilities Monitoring Network Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2012. MMWR Surveill Summ 2012, 61(3):1-19. Available at:, Accessed February 4, 2013. http://www.cdc.gov/mmwr/pdf/ss/ss6103.pdf.
3. LeCavalier L. Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics, and empirical classification. JAutism Dev Disord 2006, 36:1101-1114.
4. Dominick K.C., Davis N.O., Lainhart J., et al. Atypical behaviors in children with autism and children with a history of language impairment. Res Dev Disabil 2007, 28:145-162.
5. Parikh M.S., Kolevzon A., Hollander E. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability. JChild Adolesc Psychopharmacol 2008, 18:157-178.
6. Hartley S.L., Sikora D.M., McCoy R. Prevalence and risk factors of maladaptive behaviour in young children with autistic disorder. JIntellect Disabil Res 2008, 52:819-829.
7. Kanne S.M., Mazurek M.O. Aggression in children and adolescents with ASD: prevalence and risk factors. JAutism Dev Disord 2011, 41:926-937.
8. Mazurek M.O., Kanne S.M., Wodka E.L. Physical aggression in children and adolescents with autism spectrum disorders. Res Autism Spectr Disord 2013, 7:455-465.
9. Lecavalier L., Leone S., Wiltz J. The impact of behaviour problems on caregiver stress in young people with autism spectrum disorders. JIntellect Disabil Res 2006, 50:172-183.
10. Siegel M., Beaulieu A. Psychotropic medications in children with autism spectrum disorders: a systematic review and synthesis for evidence based practice. JAutism Dev Disord 2012, 42:1592-1605.
11. Correll C.U., Manu P., Olshanskiy V., et al. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA 2009, 302:1765-1773.
12. Research Units on Pediatric Psychopharmacology Autism Network Risperidone in children with autism and serious behavioral problems. NEngl J Med 2002, 347:314-321.
13. Martin A., Scahill L., Anderson G.M., et al. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data. Am J Psychiatry 2004, 161:1125-1127.
14. Research Units on Pediatric Psychopharmacology Autism Network Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months. Am J Psychiatry 2005, 162:1361-1369.
15. Aman M.G., McDougle C.J., Scahill L., et al. Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. JAm Acad Child Adolesc Psychiatry 2009, 48:1143-1154.
16. Jensen P.S., Youngstrom E.A., Steiner H., et al. Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies. JAm Acad Child Adolesc Psychiatry 2007, 46:309-322.
17. Marcus R.N., Owen R., Kamen L., et al. Aplacebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. JAm Acad Child Adolesc Psychiatry 2009, 48:1110-1119.
18. Owen R., Sikich L., Marcus R.N., et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 2009, 124:1533-1540.
19. Pandina G.J., Aman M.G., Findling R.L. Risperidone in the management of disruptive behavior disorders. JChild Adolesc Psychopharmacol 2006, 16:379-392.
20. Iwata B.A., Dorsey M.F., Slifer K.J., et al. Toward a functional analysis of self-injury. JAppl Behav Anal 1994, 27:197-209.
21. Schreibman L. Intensive behavioral/psychoeducational treatments for autism: research needs and future directions. JAutism Dev Disord 2000, 30:373-378.
22. Machalicek W., O'Reilly M.F., Beretvas N., et al. Areview of interventions to reduce challenging behavior in school settings for students with autism spectrum disorder. Res Autism Spectr Disord 2007, 1:229-246.
23. Krusei M.J., Keller S., Jensen J.A. Neurobiology of aggression. Pediatric psychopharmacology: principles and practice 2011, 211-225. Oxford University Press, New York. 2nd edition. A. Martin, L. Scahill, C.J. Kratochvil (Eds.).
24. Moyer K.E. Kinds of aggression and their physiological basis. Commun Behav Biol 1968, 2:65-87.
25. King S., Waschbusch D.A., Pelham W.E., et al. Subtypes of aggression in children with attention deficit hyperactivity disorder: medication effects and comparison with typical children. JClin Child Adolesc Psychol 2009, 38:619-629.
26. Dodge K.A. The structure and function of reactive and proactive aggression. The development and treatment of childhood aggression 1991, 201-218. Lawrence Erlbaum Associates, Hillsdale (NJ). D.J. Pepler, K.H. Rubin (Eds.).
27. Dodge K.A., Lochman J.E., Harnish J.D., et al. Reactive and proactive aggression in school children and psychiatrically impaired chronically assaultive youth. JAbnorm Psychol 1997, 106:37-51.
28. Ollendick T.H., Jarrett M.A., Wolff J.C., et al. Reactive and proactive aggression: cross-informant agreement and the clinical utility of different informants. JPsychopathol Behav Assess 2009, 31:51-59.
29. Farmer C.A., Aman M.G. Aggressive behavior in a sample of children with autism spectrum disorders. Res Autism Spectr Disord 2011, 5:317-323.
30. McAuliffe M.D., Hubbard J.A., Rubin R.M., et al. Reactive and proactive aggression: stability of constructs and relations to correlates. JGenet Psychol 2006, 167:365-382.
31. Kempes M., Matthys W., de Vries H., et al. Reactive and proactive aggression in children-a review of theory, findings and the relevance for child and adolescent psychiatry. Eur Child Adolesc Psychiatry 2005, 14:11-19.
32. Connor D.F., Chartier K.G., Preen E.C., et al. Impulsive aggression in attention-deficit/hyperactivity disorder: symptom severity, co-morbidity, and attention-deficit/hyperactivity disorder subtype. JChild Adolesc Psychopharmacol 2010, 20:119-126.
33. Brown E.C., Aman M.G., Havercamp S.M. Factor analysis and norms for parent ratings on the Aberrant Behavior Checklist-Community for young people in special education. Res Dev Disabil 2002, 23:45-60.
34. Aman M.G., Singh N.N., Stewart A.W., et al. Psychometric characteristics of the aberrant behavior checklist. Am J Ment Defic 1985, 89:492-502.
35. Scahill L., Aman M.G., McDougle C.J., et al. Trial design challenges when combining medication and parent training in children with pervasive developmental disorders. JAutism Dev Disord 2009, 39:720-729.
36. Scahill L., McCracken J., McDougle C.J., et al. Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism. JChild Adolesc Psychopharmacol 2001, 11:377-388.
37. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington, DC. 4th edition.
38. Le Couteur A., Lord C., Rutter M. The autism diagnostic interview-revised (ADI-R) 2003, Western Psychological Services, Los Angeles (CA).
39. Arnold L.E., Vitiello B., McDougle C., et al. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. JAm Acad Child Adolesc Psychiatry 2003, 42:1443-1450.
40. Roid G.H. Stanford Binet intelligence scales 2003, Riverside Publishing, Itasca (IL). 5th edition.
41. Wechsler D. Manual for the Wechsler intelligence scale for children 1991, Psychological Corporation, San Antonio (TX). 3rd edition.
42. Roid G.H., Miller L.J. Leiter international performance scale-revised: examiner's manual 1997, Stoelting Co, Wood Dale (IL).
43. Mullen E. The Mullen scales of early learning 1995, American Guidance Service, Circle Pines (MN).
44. Jensen J.A., Armstrong R.J. Slosson intelligence test for children and adults 1985, Slosson Educational Publications, East Aurora (NY).
45. Wechsler D. Manual for the Wechsler preschool and primary scale of intelligence-revised 1989, Psychological Corporation, San Antonio (TX).
46. Guy W. Clinical global impressions. ECDEU Assessment manual for psychopharmacology-revised (DHEW Publ No ADM 76-338) 1976, 218-222. US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, Rockville (MD).
47. Lord C., Pickles A., McLennan J., et al. Diagnosing autism: analyses of data from the Autism Diagnostic Interview. JAutism Dev Disord 1997, 27:501-517.
48. Research Units on Pediatric Psychopharmacology Autism Network A randomized, double-blind, placebo-controlled, crossover trial of methylphenidate in children with hyperactivity associated with pervasive developmental disorders. Arch Gen Psychiatry 2005, 62:1266-1274.
49. Sparrow S., Balla D., Cicchetti D. Vineland Adaptive Behavior Scales 1984, American Guidance Service, Circle Pines (MN).
50. Scahill L., Riddle M.A., McSwiggin-Hardin M., et al. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. JAm Acad Child Adolesc Psychiatry 1997, 36:844-852.
51. Scahill L., McDougle C.J., Williams S.K., Research Units on Pediatric Psychopharmacology Autism Network, et al. Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. JAm Acad Child Adolesc Psychiatry 2006, 45:1114-1123.
52. Fleiss J.L., Levin B., Paik M.C. Statistical methods for rates and proportions 2003, John Wiley & Sons, New York. 3rdedition.
53. Dodge K.A., Coie J.D. Social-information-processing factors in reactive and proactive aggression in children's peer groups. JPers Soc Psychol 1987, 53:1146-1158.
54. Vitiello B., Stoff D.M. Subtypes of aggression and their relevance to child psychiatry. JAm Acad Child Adolesc Psychiatry 1997, 36:307-315.